| __timestamp | Apellis Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 94231000 |
| Thursday, January 1, 2015 | 13730311 | 146394000 |
| Friday, January 1, 2016 | 22978599 | 188272000 |
| Sunday, January 1, 2017 | 40303878 | 166707000 |
| Monday, January 1, 2018 | 105285576 | 401843000 |
| Tuesday, January 1, 2019 | 220968770 | 560909000 |
| Wednesday, January 1, 2020 | 299921000 | 722343000 |
| Friday, January 1, 2021 | 420869000 | 771182000 |
| Saturday, January 1, 2022 | 387236000 | 877090000 |
| Sunday, January 1, 2023 | 354387000 | 877387000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. and Apellis Pharmaceuticals, Inc. have demonstrated significant investments in R&D, reflecting their dedication to advancing medical science.
Sarepta Therapeutics has consistently outpaced Apellis Pharmaceuticals in R&D spending, with a peak in 2023 where their budget reached nearly 880 million dollars, a staggering 10-fold increase from 2014. Apellis, while trailing, has shown impressive growth, with a 42-fold increase in R&D expenses over the same period.
These trends highlight the dynamic nature of the biotech industry, where strategic investments in R&D can lead to groundbreaking treatments and therapies. As these companies continue to innovate, their R&D budgets will likely remain a focal point for investors and industry analysts alike.
R&D Spending Showdown: AstraZeneca PLC vs Sarepta Therapeutics, Inc.
R&D Spending Showdown: Gilead Sciences, Inc. vs Sarepta Therapeutics, Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Apellis Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated or Apellis Pharmaceuticals, Inc.: Who Invests More in Innovation?
GSK plc vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Sarepta Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Research and Development Investment: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Ultragenyx Pharmaceutical Inc. vs Apellis Pharmaceuticals, Inc.